Endocarditis with Moraxella-like M-6 after cardiac catheterization.

Journal of Clinical Microbiology
R E Perez

Abstract

A patient developed bacteremia with CDC group M-6, a Moraxella-like bacterium, after a complicated heart catheterization. He was treated with tobramycin and ampicillin. The aortic valve was later replaced and did not show any signs of infection. The slow growth of M-6 can delay diagnosis and give misleading antibiotic susceptibility results. Penicillin is not always active against this organism.

References

Apr 11, 1985·The New England Journal of Medicine·J S Wolfson, M N Swartz
May 1, 1983·Journal of Clinical Microbiology·A E Simor, I E Salit

❮ Previous
Next ❯

Citations

Aug 1, 1993·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·L StruillouJ H Barrier
May 19, 2007·Journal of Medical Microbiology·Morgan EvansDavid P J Turner
Jun 28, 2013·The Heart Surgery Forum·Paloma Manea
Jul 4, 2003·Scandinavian Journal of Infectious Diseases·Cristina PicuThierry Prazuck
Feb 22, 2008·Journal of Medical Microbiology·Ju-Feng HsiaoPao-Hsien Chu
Jul 10, 2003·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·L J HaddowG Gopal Rao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

© 2021 Meta ULC. All rights reserved